IBDEI2JK ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43113,0)
 ;;=I83.228^^164^2060^154
 ;;^UTILITY(U,$J,358.3,43113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43113,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Oth Part LE & Inflam
 ;;^UTILITY(U,$J,358.3,43113,1,4,0)
 ;;=4^I83.228
 ;;^UTILITY(U,$J,358.3,43113,2)
 ;;=^5008009
 ;;^UTILITY(U,$J,358.3,43114,0)
 ;;=I83.91^^164^2060^46
 ;;^UTILITY(U,$J,358.3,43114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43114,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Rt LE
 ;;^UTILITY(U,$J,358.3,43114,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,43114,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,43115,0)
 ;;=I83.92^^164^2060^45
 ;;^UTILITY(U,$J,358.3,43115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43115,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Lt LE
 ;;^UTILITY(U,$J,358.3,43115,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,43115,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,43116,0)
 ;;=I83.93^^164^2060^44
 ;;^UTILITY(U,$J,358.3,43116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43116,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Bil LE
 ;;^UTILITY(U,$J,358.3,43116,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,43116,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,43117,0)
 ;;=I89.0^^164^2060^117
 ;;^UTILITY(U,$J,358.3,43117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43117,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,43117,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,43117,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,43118,0)
 ;;=I87.2^^164^2060^170
 ;;^UTILITY(U,$J,358.3,43118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43118,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,43118,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,43118,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,43119,0)
 ;;=K55.0^^164^2060^32
 ;;^UTILITY(U,$J,358.3,43119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43119,1,3,0)
 ;;=3^AC Intestine Vascular Disorders
 ;;^UTILITY(U,$J,358.3,43119,1,4,0)
 ;;=4^K55.0
 ;;^UTILITY(U,$J,358.3,43119,2)
 ;;=^5008705
 ;;^UTILITY(U,$J,358.3,43120,0)
 ;;=K55.1^^164^2060^74
 ;;^UTILITY(U,$J,358.3,43120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43120,1,3,0)
 ;;=3^Chr Intestine Vascular Disorders
 ;;^UTILITY(U,$J,358.3,43120,1,4,0)
 ;;=4^K55.1
 ;;^UTILITY(U,$J,358.3,43120,2)
 ;;=^5008706
 ;;^UTILITY(U,$J,358.3,43121,0)
 ;;=N18.9^^164^2060^75
 ;;^UTILITY(U,$J,358.3,43121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43121,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43121,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,43121,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,43122,0)
 ;;=N28.0^^164^2060^108
 ;;^UTILITY(U,$J,358.3,43122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43122,1,3,0)
 ;;=3^Kidney Ischemia & Infarction
 ;;^UTILITY(U,$J,358.3,43122,1,4,0)
 ;;=4^N28.0
 ;;^UTILITY(U,$J,358.3,43122,2)
 ;;=^5015626
 ;;^UTILITY(U,$J,358.3,43123,0)
 ;;=L03.114^^164^2060^66
 ;;^UTILITY(U,$J,358.3,43123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43123,1,3,0)
 ;;=3^Cellulitis Lt Upper Limb
 ;;^UTILITY(U,$J,358.3,43123,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,43123,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,43124,0)
 ;;=L03.113^^164^2060^68
 ;;^UTILITY(U,$J,358.3,43124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43124,1,3,0)
 ;;=3^Cellulitis Rt Upper Limb
 ;;^UTILITY(U,$J,358.3,43124,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,43124,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,43125,0)
 ;;=L03.115^^164^2060^67
 ;;^UTILITY(U,$J,358.3,43125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43125,1,3,0)
 ;;=3^Cellulitis Rt Lower Limb
 ;;^UTILITY(U,$J,358.3,43125,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,43125,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,43126,0)
 ;;=L03.116^^164^2060^65
